A new approach for the synthesis of pharmaceutically relevant fluorinated phenanthridines

FHS
June 26, 2023
4:45 pm

Phenanthridines are heterocyclic compounds consisting of two six-membered benzene rings fused to a six-membered ring containing nitrogen.

Startup BioAge raises $170 million Series D for Zepbound combination therapy

A California biotech developing a combination therapy with the obesity drug Zepbound has raised a $170 million Series D round. The company, BioAge, raised money

February 13, 2024

Akili cuts 40% of workforce, plans shift to non-prescription model

Dive Brief: Boston-based digital therapeutics company Akili Interactive announced Wednesday that it is restructuring its business, including cutting 40% of its staff. The company, which

September 13, 2023

Patient Develops Inflamed Rash After Double Mastectomy

A 42-year-old woman with asthma developed an itchy, inflamed rash on her chest after undergoing a double mastectomy, reported Austinn Miller, MD, of Dermatology Associates

September 6, 2023

Supercharge Your Portfolio with Future Health Stocks!

Join us for Profitable Insights & Expert Tips!

With expert analysis, comprehensive market coverage, and actionable insights, our newsletter equips you with the knowledge & tools necessary to make informed decisions & maximize your potential returns in the dynamic world of future health stocks.